PeptideDB

mPEG-Mal (MW 750) (mPEG-Maleimide (MW 750); Methoxypolyethylene glycol maleimide (MW 750)) 724722-89

mPEG-Mal (MW 750) (mPEG-Maleimide (MW 750); Methoxypolyethylene glycol maleimide (MW 750)) 724722-89

CAS No.: 724722-89-8

mPEG-Mal (MW 750) is a PEG analogue used for thiol pegylation of protein molecules. Its maleimide group (-Mal) degrades
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

mPEG-Mal (MW 750) is a PEG analogue used for thiol pegylation of protein molecules. Its maleimide group (-Mal) degrades in aqueous media and has been used in drug delivery studies.

Physicochemical Properties


Molecular Weight 750(Average)
Exact Mass 270.121
CAS # 724722-89-8
Related CAS # mPEG-Mal;724722-89-8
PubChem CID 58005095
Appearance White to off-white solid powder
Melting Point 48-52 °C
LogP -0.5
Hydrogen Bond Donor Count 1
Hydrogen Bond Acceptor Count 5
Rotatable Bond Count 9
Heavy Atom Count 19
Complexity 349
Defined Atom Stereocenter Count 0
InChi Key JCTGVOWJPZBVHT-UHFFFAOYSA-N
InChi Code

InChI=1S/C12H18N2O5/c1-18-8-9-19-7-5-13-10(15)4-6-14-11(16)2-3-12(14)17/h2-3H,4-9H2,1H3,(H,13,15)
Chemical Name

3-(2,5-dioxopyrrol-1-yl)-N-[2-(2-methoxyethoxy)ethyl]propanamide
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


References

[1]. Development of a spectrophotometric biphasic assay for the estimation of mPEG-maleimide in thiol PEGylation reaction mixtures. Chemical Engineering Communications, 2016, 203(11): 1464-1472.

Additional Infomation See also: Methoxy peg maleimide (20000 MW) (annotation moved to).

Solubility Data


Solubility (In Vitro) DMSO : ~50 mg/mL
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (Infinity mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (Infinity mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 3: ≥ 2.5 mg/mL (Infinity mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)